Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Head & Neck 1Genitourinary 1Breast 1

Conditions

Skin Neoplasms 2

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Optical Imaging × Dermatologic × Clear all
NCT01662713 2023-03-15

OFDI

Massachusetts General Hospital

Phase NA Completed
10 enrolled
Dermatologic

Skin Neoplasms

NCT00432471 2017-06-28

Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡